Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn

Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn

Perrigo Company, a listed Irish healthcare and pharmaceutical company, has signed a binding offer to acquire HRA Pharma, a French consumer self-care company, from Astorg and Goldman Sachs Asset Management for EUR 1.8bn in cash.

Read Previous

Hedge funds gain as political risks rise

Read Next

KKR fully exits SoftwareOne

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.